JPMorgan launches 5‑yr notes linked to MerQube index
JPMorgan Chase Financial Company LLC offers structured Uncapped Accelerated Barrier Notes linked to the MerQube US Tech+ Vol Advantage Index.
JPMorgan Chase Financial Company LLC offers structured Uncapped Accelerated Barrier Notes linked to the MerQube US Tech+ Vol Advantage Index. The notes are expected to price on or about July 10, 2026 and settle on or about July 15, 2026, mature on July 15, 2031, and carry an Upside Leverage Factor of at least 2.91 with a Barrier Amount of 50.00% of the Initial Value.
Payments: if the Index finishes above its Initial Value, investors receive $1,000 plus the Index Return times the Upside Leverage Factor; if the Final Value is at or above the Barrier but not above the Initial Value, investors receive principal; if below the Barrier, investors suffer proportional principal loss. The Index reflects a 6.0% per annum daily deduction and a notional financing cost, both of which reduce index performance. The notes are unsecured obligations of JPMorgan Financial and are guaranteed by JPMorgan Chase & Co.; they are not bank deposits and are not FDIC-insured.
Positive
- None.
Negative
- None.
Insights
Product mixes leveraged upside with high index-level deductions and barrier risk.
The notes offer amplified upside via an Upside Leverage Factor of at least 2.91, but the Index applies a 6.0% per annum daily deduction and a notional financing cost that materially drag index returns; these deductions are explicit inputs to pricing and reduce the Index level.
Key dependencies include realized QQQ implied volatility (which determines the Index exposure), the weekly rebalance schedule, and the magnitude of the daily deductions. Secondary‑market liquidity is limited; issuers expect repurchase support to decline over an initial predetermined period (the shorter of six months and one-half the term).
Tax treatment is opinion‑based and could change with IRS guidance.
Special tax counsel opines the notes may be treated as open transactions (not debt) with capital gain/loss treatment for U.S. Holders holding over a year, but the IRS or courts could disagree. Section 871(m) treatment was evaluated and issuer expects it not to apply to Non‑U.S. Holders under stated determinations.
Investors should note the filing highlights potential future regulatory or guidance changes that could materially alter timing or character of income; consult a tax adviser for personalized analysis.
Key Figures
Key Terms
notional financing cost financial
Upside Leverage Factor financial
Barrier Amount financial
open transactions regulatory
Section 871(m) tax
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What payout profile do JPM's notes linked to MQUSTVA offer?
What happens if the Index falls below the Barrier Amount?
How do the 6.0% deduction and notional financing cost affect returns?
When will the notes price and settle for the July 2026 issue?
What is the estimated value versus issue price shown by JPMorgan?
AI-generated analysis. How Rhea-AI works. Not financial advice.